Skip to main content
Premium Trial:

Request an Annual Quote

Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark

NEW YORK — Vela Diagnostics said on Monday that an automated version of its ViroKey SARS-CoV-2 RT-PCR Test has received CE-IVD marking, as well as provisional authorization from Singapore's Health Sciences Authority.

The test detects SARS-CoV-2 by targeting conserved regions of the SARS-CoV-2 ORF1a and N genes. It runs on the Singapore-based company's Sentosa SX101 instrument, in conjunction with its Sentosa SA201 instrument or Thermo Fisher Scientific's ABI 7500 Fast Dx and can perform up to 48 tests on a single run.

A nonautomated version of the test received CE-IVD marking in April. Vela developed both tests with $225,000 in Biomedical Advanced Research and Development Authority funding.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.